Evidence map›Paper›PMID 21734645›Full record

ArticleMolecular systems biology2011

Cell-to-cell variability of alternative RNA splicing.

Zeev Waks, Allon M Klein, Pamela A Silver

Abstract read
In one paragraph

Article in Molecular systems biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. In Situ Imaging of mRNA Splicing Variants by SpliceRCA.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  11. Imaging Organization of RNA Processing within the Nucleus.Cold Spring Harbor perspectives in biology · 2021
    Review
  12. Revised Exon Structure of l-DOPA Decarboxylase (International journal of molecular sciences · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Imaging the Life and Death of mRNAs in Single Cells.Cold Spring Harbor perspectives in biology · 2018
    Review
  19. Article
  20. SpliceRCA:ACS central science · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Zeev WaksDepartment of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Allon M Klein
Pamela A Silver

Funding

COORDINATION OF PROCESSING AND TRANSPORT OF MRNASR01GM057476 · NIGMS · HARVARD MEDICAL SCHOOL · PI SILVER, PAMELA A · 1998 to 2010
$4.3M
Transport of Proteins In and Out of the NucleusR37GM036373 · NIGMS · HARVARD MEDICAL SCHOOL · PI SILVER, PAMELA A · 2003 to 2012
$4.3M
TRANSPORT OF PROTEINS IN AND OUT OF THE NUCLEUSR01GM036373 · NIGMS · PRINCETON UNIVERSITY · PI SILVER, PAMELA A · 1986 to 2016
$2.5M
NIGMS NIH HHS GM057476NIGMS NIH HHS GM36373NIGMS NIH HHS R01 GM036373NIGMS NIH HHS R01 GM057476NIGMS NIH HHS R37 GM036373
6 · The paper itself

Abstract

Heterogeneity in the expression levels of mammalian genes is large even in clonal populations and has phenotypic consequences. Alternative splicing is a fundamental aspect of gene expression, yet its contribution to heterogeneity is unknown. Here, we use single-molecule imaging to characterize the cell-to-cell variability in mRNA isoform ratios for two endogenous genes, CAPRIN1 and MKNK2. We show that isoform variability in non-transformed, diploid cells is remarkably close to the minimum possible given the stochastic nature of individual splicing events, while variability in HeLa cells is considerably higher. Analysis of the potential sources of isoform ratio heterogeneity indicates that a difference in the control over splicing factor activity is one origin of this increase. Our imaging approach also visualizes non-alternatively spliced mRNA and active transcription sites, and yields spatial information regarding the relationship between splicing and transcription. Together, our work demonstrates that mammalian cells minimize fluctuations in mRNA isoform ratios by tightly regulating the splicing machinery.

Indexed as

Alternative SplicingCell Cycle ProteinsCell SurvivalGene Expression RegulationGene Knockdown TechniquesHeLa CellsHumansIn Situ Hybridization, FluorescenceIntracellular Signaling Peptides and ProteinsProtein IsoformsProtein Serine-Threonine KinasesReverse Transcriptase Polymerase Chain ReactionRNA, MessengerTranscription, GeneticCAPRIN1 protein, humanCell Cycle ProteinsIntracellular Signaling Peptides and ProteinsMKNK2 protein, humanProtein IsoformsProtein Serine-Threonine KinasesRNA, Messenger

Identifiers

PMID21734645
PMCPMC3159976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.